Greater Glasgow and Clyde Medicines

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC).  The new format, which is aimed at the public and patients is currently being piloted.

For full details of the medicines included in this post that are available for use, please see the relevant entry in the GGC Formulary.

 Oral Proton Pump Inhibitors

• Archived March 2023.

Refer to PPI blog series:

• General overview of oral Proton Pump Inhibitors (PPIs)
• Proton pump inhibitors (PPIs): potential link with Clostridioides difficile infection and pneumonia
• Proton Pump Inhibitors (PPIs): Adverse Effects Reported by the MHRA

Greater Glasgow and Clyde Area Drug and Therapeutics Committee met on Monday 14th December. This blog details the Formulary decisions made at that meeting.

Management of Urinary Incontinence and Overactive Bladder

Archived February 2022.

Greater Glasgow and Clyde Area Drug and Therapeutics Committee met on Monday 19th October. This blog details the Formulary decisions made at that meeting.

ADTC met on Monday 17th August. This blog entry contains all the Formulary decisions from that meeting.

ADTC met on Monday 8th January. This blog entry contains all the Formulary decisions from that meeting

ADTC met on 20th April 2015. This blog entry contains all the Formulary decisions from that meeting

ADTC met on 15th Feb - this blog entry contains all the Formulary decisions from that meeting

Greater Glasgow and Clyde Area Drug and Therapeutics Committee (ADTC) met on 8th December 2014. The Formulary decisions from that meeting are summarised in this post